ALKBH5 also removes the m6A modification of JAK1 mRNA, leading to upregulation of JAK1 expression mediated by LINC00659 in an m6A-YTHDF2-dependent manner, consequently activating the JAK1/STAT3 pathway in gastric cancer. Here, ALKBH5 is linked to gastric cancer.